Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Dr. Peter Schur Discusses Lupus Treatment, Management Advances in Past 50 Years

Vanessa Caceres  |  Issue: June 2017  |  June 13, 2017

The role of immunity is another crucial area under investigation. “The identification of receptors by which DNA can stimulate immune responses would include TLRs and other internal nucleic acid receptors. Major questions in lupus relate to the origin of the anti-DNA response and the ways in which DNA can stimulate immunity. The discovery of the TLRs and other sensors provides insight into how DNA may drive immune responses,” Dr. Schur says. The use of transgenic mice, such as those that express anti-DNA antibodies, have been important to help understand issues of tolerance and defining events such as receptor editing.

“The identification of cytokines, chemokines, interferon, BAFF, B cells, T cells and other cells of regulating are key steps in lupus. I would include the studies on the interferon signature in this category and the characterization of cytokines, such as BAFF, including mouse models to understand its role,” he says. “These studies have been important in understanding functional immune disturbances contributing to lupus, as well as presenting new targets for therapy.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The study of epigenetics within lupus also has evolved, Dr. Schur says. Epigenetics has helped pinpoint that smoking and sun exposure are two major things that those with lupus should avoid.


Vanessa Caceres is a medical writer in Bradenton, Fla.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsResearch RheumSystemic Lupus Erythematosus Tagged with:DiagnosisDr. Peter SchurLupusManagementPathogenesisResearchRheumatic DiseaserheumatologySLESystemic lupus erythematosusTreatment

Related Articles

    A 52-Year-Old Lupus Paper Remains Important Today

    December 14, 2020

    Over 50 years ago, an article appeared in The New England Journal of Medicine: “Immunologic Factors and Clinical Activity in Systemic Lupus Erythema­tosus.”1 Written by a young postdoctoral fellow, Peter H. Schur, MD, and colleagues, the article synthesized important work in the field at the time. What follows is a discussion of the historical context…

    Laboratory Testing for Diagnosis, Management of Patients with Rheumatic Disease

    December 1, 2014

    A review of data on antinuclear antibodies and tests for rheumatoid arthritis

    Know Your Labs

    February 1, 2009

    A review of state-of-the-art testing for SLE and connective tissue disease.

    Cure, Effective Treatment for Lupus Nephritis Remain Elusive Despite Advances

    December 1, 2014

    Rheumatology experts review history of LN, offer explanations for roadblocks to better therapies

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences